The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan

Research in Social and Administrative Pharmacy

Volumn 5, Issue 3, 2009, Pages 211-224

  Chen, Li Chia ^a   Schafheutle, Ellen I ^a   Noyce, Peter R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Co payment; Health care cost; Medical utilization; Referral system

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; COST; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; OUTPATIENT; OUTPATIENT DEPARTMENT; PHARMACY; PUBLIC HEALTH; STATISTICAL ANALYSIS; STATISTICS; TAIWAN; UTILIZATION REVIEW;

AMBULATORY CARE FACILITIES; COSTS AND COST ANALYSIS; DATA INTERPRETATION, STATISTICAL; DELIVERY OF HEALTH CARE; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; INSURANCE, PHARMACEUTICAL SERVICES; NATIONAL HEALTH PROGRAMS; OUTPATIENTS; PHARMACIES; PRESCRIPTION DRUGS; TAIWAN;

EID: 69549103248     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.08.003     Document Type: Article

References (31)

1. Lu J.F., and Hsiao W.C. Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff 22 (2003) 77-88
2. Cheng S.H., and Chiang T.L. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA 278 (1997) 89-93
3. DiPiero A. Universal problems and universal healthcare: 6 countries-6 systems, Healthcare Forum. Oregons' Future, Fall 2004, 27-31.
4. Huang W.F., and Chiang H.C. Pharmaceutical benefit scheme and cost containment in Taiwan's National Health Insurance. J Pharm Financ Econ Policy 12 (2004) 133-149
5. Liu S.Z., and Romeis J.C. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Med Care 41 (2003) 1331-1342
6. Liu S.Z., and Romeis J.C. Changes in drug utilization following the outpatient prescription drug cost-sharing program-evidence from Taiwan's elderly. Health Policy 68 (2004) 277-287
7. Chen T.J., Chou L.F., and Hwang S.J. Patterns of ambulatory care utilization in Taiwan. BMC Health Serv Res 6 (2006) 54
8. Burt C.W., and Schappert S.M. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999-2000. Vital health Stat 13 157 (2004) 1-70
9. Bureau of National Health Insurance. The National Health Insurance Statistics 2001. Available at: (2002). http://www.nhi.gov.tw/english/webdata.asp?menu=11&menu_id=296&we bdata_id=1944 Accessed 15.07.06
10. Hu TW, Hsich CR. An Economic Analysis of Health Care Reform in Taiwan. Paper presented at the Menorial Oonference for Professor Kou-Shu-Shu Liang, Taipei, Taiwan, 1999.
11. Huang J.-H., and Tung C.-M. The effects of outpatient co-payment policy on healthcare usage by the elderly in Taiwan. Arch Gerontol Geriatr 43 (2006) 101-116
12. Effects of cost-sharing in Taiwan, National Health Insurance System: some empirical results. Paper presented in Taipei International Conference on Health Economics. Academia Sinica, 1999.
13. Atella V., Schafheutle E., Noyce P., and Hassell K. Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK. Appl Health Econ Health Policy 4 (2005) 23-35
14. Hassell K., Atella V., Schafheutle E.I., Weiss M.C., and Noyce P.R. Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison. Eur J Public Health 13 (2003) 18-23
15. Schafheutle E.I., Hassell K., Noyce P.R., and Weiss M.C. Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Community 10 (2002) 187-195
16. Schafheutle E.I., Hassell K., and Noyce P.R. Coping with prescription charges in the UK. Int J Pharm Prac 12 (2004) 239-246
17. Weiss M.C., Hassell K., Schafheutle E.I., and Noyce P.R. Strategies used by general practitioners to minimise the impact of the prescription charge. Eur J Gen Pract 7 (2001) 23-26
18. Lee M.C., and Jones A.M. How did dentists respond to the introduction of global budgets in Taiwan? An evaluation using individual panel data. Int J Health Care Finance Econ 4 (2004) 307-326
19. Chen T.J., Chou L.F., and Hwang S.J. Application of concentration ratios to analyze the phenomenon of "next-door" pharmacy in Taiwan. Clin Ther 28 (2006) 1225-1230
20. Chou Y.J., Yip W.C., Lee C.-H., Huang N., Sun Y.-P., and Chang H.-J. Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience. Health Policy Plan 18 (2003) 316-329
21. Gillings D., Makuc D., and Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health 71 (1981) 38-46
22. Wagner A.K., Soumerai S.B., Zhang F., and Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27 (2002) 299-309
23. Lee Y.C., Yang M.C., Huang Y.T., Liu C.H., and Chen S.B. Impacts of cost containment strategies on pharmaceutical expenditures of the national health insurance in Taiwan, 1996-2003. Pharmacoeconomics 24 (2006) 891-902
24. Liu L.-M. Analysis of time series with calendar effects. Manag Sci 26 (1980) 106-112
25. Hartung D.M., Touchette D.R., Ketchum K.L., Haxby D.G., and Goldberg B.W. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Clin Ther 26 (2004) 1518-1532
26. Strom B.L., and Carson J.L. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev 12 (1990) 87-107
27. Liu C.T., Yang P.T., Yeh Y.T., and Wang B.L. The impacts of smart cards on hospital information systems-an investigation of the first phase of the national health insurance smart card project in Taiwan. Int J Med Inf 75 (2006) 173-181
28. Soumerai S.B., McLaughlin T.J., Ross-Degnan D., Casteris C.S., and Bollini P. Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 331 (1994) 650-655
29. Stuart B., and Grana J. Ability to pay and the decision to medicate. Med Care 36 (1998) 202-211
30. Lundberg L., Johannesson M., Isacson D.G., and Borgquist L. Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy 44 (1998) 123-134
31. Noyce P.R., Huttin C., Atella V., Brenner G., Haaijer-Ruskamp F.M., Hedvall M.-B., and Mechtler R. The cost of prescription medicines to patients. Health Policy 52 (2000) 129-145